Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  29 (2025)
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 24 , ISSUE 3 ( March, 2020 ) > List of Articles

CASE REPORT

Extended Continuous Infusion of Methylene Blue for Refractory Septic Shock

Abhishek Jaiswal, Elizabeth Silver

Keywords : Extra corporeal membrane oxygenation, Methylene blue, Refractory shock, Sepsis induced

Citation Information : Jaiswal A, Silver E. Extended Continuous Infusion of Methylene Blue for Refractory Septic Shock. Indian J Crit Care Med 2020; 24 (3):206-207.

DOI: 10.5005/jp-journals-10071-23376

License: CC BY-NC 4.0

Published Online: 25-10-2011

Copyright Statement:  Copyright © 2020; The Author(s).


Abstract

Objective: Highlight the utility of methylene blue (MTB) infusion for extended period for refractory vasoplegia. Introduction: Hypotension refractory to vasopressor therapy in sepsis is associated with high mortality and limited therapeutic options. Dysregulated nitric oxide (NO) pathway seems to be a major driver, and, therefore, MTB, which inhibits inducible NO synthase activity and decreases cyclic guanosine monophosphate (GMP) accumulation by directly competing with NO by binding to soluble guanylyl cyclase, has been explored. Case description: We describe a successful reversal of refractory septic shock with prolonged MTB infusion in a patient supported on multiple vasopressors at the highest clinical doses as well as venovenous extracorporeal membrane oxygenation (VV-ECMO). Conclusion and clinical significance: Current report suggests a potential role of MTB infusion in refractory vasoplegia even in advanced vasoplegic shock.

HTML PDF Share
  1. Preiser JC, Lejeune P, Roman A, Carlier E, De Backer D, Leeman M, et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med 1995;23(2):259–264. DOI: 10.1097/00003246-199502000-00010.
  2. Brown G, Frankl D, Phang T. Continuous infusion of methylene blue for septic shock. Postgrad Med J 1996;72(852):612–614. DOI: 10.1136/pgmj.72.852.612.
  3. Paciullo CA, McMahon Horner D, Hatton KW, Flynn JD. Methylene blue for the treatment of septic shock. Pharmacotherapy 2010;30(7):702–715. DOI: 10.1592/phco.30.7.702.
  4. Kwok ES, Howes D. Use of methylene blue in sepsis: a systematic review. J Intensive Care Med 2006;21(6):359–363. DOI: 10.1177/0885066606290671.
  5. Belletti A, Musu M, Silvetti S, Saleh O, Pasin L, Monaco F, et al. Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS One 2015;10(11):e0142605. DOI: 10.1371/journal.pone.0142605.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.